This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Hovione Holding Limited. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Inventor Filipa Maia: Innovating Inhalation Powder Technology
Introduction
Filipa Maia, based in Póvoa de Santa Iria, Portugal, is an innovative inventor making strides in the field of inhalation powder technology. She holds a patent for a groundbreaking multi-nozzle spray dryer device and method, enhancing the efficiency of producing inhalation powders suitable for pharmaceutical applications.
Latest Patents
Filipa Maia is credited with a patent titled "Multi-nozzle spray dryer, method for scale-up of spray dried inhalation powders, multi-nozzle apparatus and use of multiple nozzles in a spray dryer." This invention presents a spray dryer designed to prepare particles for inhalation. It incorporates a multi-nozzle apparatus with multiple single nozzles that efficiently handle drying gas flow rates exceeding 80 kg/h. The invention outlines a method for scaling-up the spray drying process from smaller to larger systems while ensuring effective production of inhalation powders, particularly targeting mean particle sizes of less than 5 microns.
Career Highlights
Filipa Maia's work at Hovione Holding Limited has positioned her as a key player in pharmaceutical innovations. Her unique approach combines engineering with pharmaceutical needs, demonstrating a commitment to improving inhalation therapies. Her patent significantly contributes to the efficiency and efficacy of inhalation powder production.
Collaborations
Throughout her career, Filipa Maia has collaborated with notable professionals in her field, including José Luis Santos and Luis Olival. These partnerships have fostered an environment of creativity and problem-solving, essential elements for advancing technology related to inhalation powders.
Conclusion
Filipa Maia's contributions to the field of inhalation technology through her innovative patent exemplify the impact of dedicated inventors on pharmaceutical advancements. Her work enhances the production of inhalation powders, potentially improving therapeutic outcomes for patients worldwide. As she continues to innovate, her influence in the industry is expected to grow, setting new standards for inhalation therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile